NCT04417465 2025-09-25
First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors
AbbVie
Phase 1 Completed
Clinical Trials
6 trialsNCT03425279 2025-09-23
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
BioAtla, Inc.
Phase 1/2 Completed
NCT03868046 2025-04-01
AUTENTIC
Hospital Universitario Araba
Completed
NCT05934214 2024-03-05
EXIT
Groupe Hospitalier Pitie-Salpetriere
Completed
NCT03790488 2023-07-03
Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies
Jounce Therapeutics, Inc.
Phase 1 Completed
NCT03492242 2019-09-26
CHIMeRA
Groupe Hospitalier Pitie-Salpetriere
Completed